EBNEO Commentary: Patent Ductus Arteriosus (PDA)-To treat early or not with ibuprofen?
April 20, 2024
MANUSCRIPT CITATION Gupta S, Subhedar NV, Bell JL, et al. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprof ...
Read more EBNEO COMMENTARY: REDUCING EXTUBATION FAILURE IN EXTREME PRETERM INFANTS – HIGHER VS STANDARD nCPAP
February 24, 2024
MANUSCRIPT CITATION Kidman AM, Manley BJ, Boland RA, et al. Higher versus lower nasal continuous positive airway pressure for extuba ...
Read more EBNEO Commentary: Umbrella Review Evaluating Interventions to Decrease Risk of Bronchopulmonary Dysplasia in Preterm Neonates
January 06, 2024
EBNEO Commentary: Umbrella Review Evaluating Interventions to Decrease Risk of Bronchopulmonary Dysplasia in Preterm Neonates MANUSCR ...
Read more EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?
September 11, 2023
EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD? Manuscript Citation Gentl ...
Read more
EBNEO COMMENTARY: Precision management of the patent ductus arteriosus in micropreemies
May 17, 2023
Precision management of the patent ductus arteriosus in micropreemies MANUSCRIPT CITATION Giesinger RE, Hobson AA, Bischoff AR, Klei ...
Read more EBNEO Commentary: Fluid Balance as a Critical Factor in Neonatal Outcomes
March 09, 2023
PDF Here MANUSCRIPT CITATION Starr MC, Griffin ...
Read more EBNEO Commentary: Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia
August 16, 2022
Manuscript citation: Watterberg KL, Walsh MC, Li L, Chawla S, D'Angio CT, Goldberg RN, et al.; Eunice Kennedy Shriver NICHD Neonatal ...
Read more OPTIMIST-ically moving towards targeted non-invasive surfactant therapy?
January 14, 2022
MANUSCRIPT CITATION Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derr ...
Read more Does azithromycin eradicate Ureaplasma in preterm infants?
January 14, 2022
MANUSCRIPT CITATION Viscardi RM, Terrin ML, Magder LS, et al. Randomised trial of azithromycin to eradicate Ureaplasma in prete ...
Read more A network meta-analysis of postnatal corticosteroids for bronchopulmonary dysplasia: has the most appropriate treatment been revealed?
January 13, 2022
MANUSCRIPT CITATION Ramaswamy VV, Bandyopadhyay T, Nanda D, Bandiya P, Ahmed J, Garg A, Roehr CC, Nangia S. Assessment of Postnatal C ...
Read more Effect of systematic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years’ corrected age
January 06, 2022
MANUSCRIPT CITATION Halbmeijer NM, Onland W, Cools F, Swarte R, van der Heide-Jalving M, Merkus MP, van Kaam AH. Effect of Systemic H ...
Read more Changes in PDA Treatment Strategy and Respiratory Outcomes: Optimal Timing and Shunts to Intervene … Continuing the Long Conversation
July 13, 2021
MANUSCRIPT CITATION Relangi, D., et al. (2021). "Changes in PDA Treatment Strategy and Respiratory Outcomes in Premature Infants." Th ...
Read more